Alnylam Pharmaceuticals Inc’s recently made public that its Director SCHULMAN AMY W unloaded Company’s shares for reported $2.04 million on Jun 25 ’24. In the deal valued at $240.00 per share,8,500 shares were sold. As a result of this transaction, SCHULMAN AMY W now holds 8,436 shares worth roughly $2.05 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Greenstreet Yvonne sold 8,301 shares, generating $1,917,475 in total proceeds. Upon selling the shares at $230.99, the Chief Executive Officer now owns 80,534 shares.
Before that, Garg Pushkal sold 2,103 shares. Alnylam Pharmaceuticals Inc shares valued at $485,773 were divested by the CMO & EVP Dev & Med Affairs at a price of $230.99 per share. As a result of the transaction, Garg Pushkal now holds 15,609 shares, worth roughly $3.79 million.
Goldman downgraded its Alnylam Pharmaceuticals Inc [ALNY] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”a Peer perform”‘ rating. Wells Fargo began covering ALNY with “an Equal weight” recommendation on December 08, 2023. Wells Fargo started covering the stock on December 08, 2023. It rated ALNY as “an Equal weight”.
Price Performance Review of ALNY
On Friday, Alnylam Pharmaceuticals Inc [NASDAQ:ALNY] saw its stock fall -1.62% to $243.00. Over the last five days, the stock has gained 46.65%. Alnylam Pharmaceuticals Inc shares have risen nearly 26.95% since the year began. Nevertheless, the stocks have risen 28.71% over the past one year. While a 52-week high of $252.87 was reached on 06/27/24, a 52-week low of $141.98 was recorded on 04/25/24. SMA at 50 days reached $159.62, while 200 days put it at $165.96. A total of 3.25 million shares were traded, compared to the trading of 2.62 million shares in the previous session.
Levels Of Support And Resistance For ALNY Stock
The 24-hour chart illustrates a support level at 239.56, which if violated will result in even more drops to 236.13. On the upside, there is a resistance level at 247.87. A further resistance level may holdings at 252.75. The Relative Strength Index (RSI) on the 14-day chart is 86.69, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 57.78, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.66%. Stochastics%K at 93.57% indicates the stock is a selling.
